Jazz spins out slimmed down EUSA

EUSA Pharma has officially re-launched following its acquisition of five approved specialty hospital products, a multi-national commercial infrastructure and the EUSA Pharma brand name from Jazz Pharmaceuticals for $34m.

EUSA Pharma has officially re-launched following its acquisition of five approved specialty hospital products, a multi-national commercial infrastructure and the EUSA Pharma brand name from Jazz Pharmaceuticals for $34m.

The acquisition of the original EUSA Pharma by Jazz for around $700m in 2012 was driven by its then lead...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category